[Secondary open-angle glaucoma: pseudoexfoliative glaucoma, pigmentary glaucoma and neovascular glaucoma].
Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom.
Increased intraocular pressure
Laser iridotomy
Panretinal laser coagulation
Prophylaxis
Treatment
Journal
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
accepted:
22
02
2022
pubmed:
2
4
2022
medline:
15
4
2022
entrez:
1
4
2022
Statut:
ppublish
Résumé
Secondary open-angle glaucomas are a heterogeneous group of diseases in which a variety of pathophysiological mechanisms result in an elevation of intraocular pressure. This article is the first part of a review of the more common forms of secondary open-angle glaucomas. The pathogenesis, characteristic clinical findings and treatment of pseudoexfoliative glaucoma, pigmentary glaucoma and neovascular glaucoma are discussed. An emphasis is placed on the differences in treatment compared to primary open-angle glaucoma and prophylactic treatment approaches are explained where possible. Die sekundären Offenwinkelglaukome sind eine heterogene Gruppe von Erkrankungen, bei denen unterschiedliche Pathomechanismen zu einem Anstieg des Augendrucks führen. Dieser Beitrag stellt den ersten Teil einer Übersicht über die häufigsten Formen dar. Die Pathogenese, das typische klinische Erscheinungsbild und die Therapie der Pseudoexfoliations‑, Pigment- und Neovaskularisationsglaukome werden diskutiert. Insbesondere werden Unterschiede in der Behandlung gegenüber den primären Offenwinkelglaukomen herausgearbeitet und – wo möglich – prophylaktische Therapieansätze erörtert.
Autres résumés
Type: Publisher
(ger)
Die sekundären Offenwinkelglaukome sind eine heterogene Gruppe von Erkrankungen, bei denen unterschiedliche Pathomechanismen zu einem Anstieg des Augendrucks führen. Dieser Beitrag stellt den ersten Teil einer Übersicht über die häufigsten Formen dar. Die Pathogenese, das typische klinische Erscheinungsbild und die Therapie der Pseudoexfoliations‑, Pigment- und Neovaskularisationsglaukome werden diskutiert. Insbesondere werden Unterschiede in der Behandlung gegenüber den primären Offenwinkelglaukomen herausgearbeitet und – wo möglich – prophylaktische Therapieansätze erörtert.
Identifiants
pubmed: 35362756
doi: 10.1007/s00347-022-01609-3
pii: 10.1007/s00347-022-01609-3
doi:
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
425-438Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
EGS (2021) European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 105:1–169. https://doi.org/10.1136/bjophthalmol-2021-egsguidelines
doi: 10.1136/bjophthalmol-2021-egsguidelines
Schlötzer-Schrehardt U, Zenkel M (2019) The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res 189:107818. https://doi.org/10.1016/j.exer.2019.107818
doi: 10.1016/j.exer.2019.107818
pubmed: 31563608
Ringvold A, Blika S, Sandvik L (1997) Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75:255–256. https://doi.org/10.1111/j.1600-0420.1997.tb00767.x
doi: 10.1111/j.1600-0420.1997.tb00767.x
pubmed: 9253968
Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86. https://doi.org/10.1016/s0002-9394(99)00255-x
doi: 10.1016/s0002-9394(99)00255-x
pubmed: 10653417
Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687. https://doi.org/10.1016/s0002-9394(14)70908-0
doi: 10.1016/s0002-9394(14)70908-0
pubmed: 9372724
Karger RA, Jeng SM, Johnson DH et al (2003) Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma 12:193–197. https://doi.org/10.1097/00061198-200306000-00002
doi: 10.1097/00061198-200306000-00002
pubmed: 12782834
Puska PM (2002) Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma: a prospective 10-year follow-up study. J Glaucoma 11:517–524. https://doi.org/10.1097/00061198-200212000-00012
doi: 10.1097/00061198-200212000-00012
pubmed: 12483098
Ekström C (1993) Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma. Acta Ophthalmol 71:189–195. https://doi.org/10.1111/j.1755-3768.1993.tb04989.x
doi: 10.1111/j.1755-3768.1993.tb04989.x
Mitchell P, Wang JJ, Hourihan F (1999) The relationship between glaucoma and pseudoexfoliation: the blue mountains eye study. Arch Ophthalmol 117:1319–1324. https://doi.org/10.1001/archopht.117.10.1319
doi: 10.1001/archopht.117.10.1319
pubmed: 10532440
Topouzis F, Harris A, Wilson MR et al (2009) Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki eye study. Am J Ophthalmol 148:606–613.e1. https://doi.org/10.1016/j.ajo.2009.03.024
doi: 10.1016/j.ajo.2009.03.024
pubmed: 19427989
Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265–315. https://doi.org/10.1016/s0039-6257(00)00196-x
doi: 10.1016/s0039-6257(00)00196-x
pubmed: 11166342
Helbig H, Schlötzer-Schrehardt U, Noske W et al (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3:148–153
pubmed: 8038683
Konstas AGP, Holló G, Irkec M et al (2007) Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 91:757. https://doi.org/10.1136/bjo.2006.106690
doi: 10.1136/bjo.2006.106690
pubmed: 17124241
Sandhu S, Damji KF (2018) Laser management of glaucoma in exfoliation syndrome. J Glaucoma 27:S91–S94. https://doi.org/10.1097/ijg.0000000000000909
doi: 10.1097/ijg.0000000000000909
pubmed: 29419644
Holló G, Katsanos A, Konstas A‑G (2015) Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol 9:907–919. https://doi.org/10.2147/opth.s77570
doi: 10.2147/opth.s77570
pubmed: 26045655
pmcid: 4447167
Serguhn S, Spiegel D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Pseudoexfoliationsglaukom und primärem chronischen Offenwinkelglaukom. Klin Monbl Augenheilkd 215:281–286. https://doi.org/10.1055/s-2008-1034715
doi: 10.1055/s-2008-1034715
pubmed: 10609242
Gillies WE, Brooks AM (2002) Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 30:176–187. https://doi.org/10.1046/j.1442-9071.2002.00513.x
doi: 10.1046/j.1442-9071.2002.00513.x
pubmed: 12010209
Tojo N, Hayashi A (2021) Ex-Press® versus Baerveldt implant surgery for primary open-angle glaucoma and pseudo-exfoliation glaucoma. Int Ophthalmol 41:1091–1101. https://doi.org/10.1007/s10792-020-01668-y
doi: 10.1007/s10792-020-01668-y
pubmed: 33515393
Ollikainen ML, Puustjärvi TJ, Rekonen PK et al (2011) Mitomycin C‑augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. Acta Ophthalmol 89:548–555. https://doi.org/10.1111/j.1755-3768.2009.01772.x
doi: 10.1111/j.1755-3768.2009.01772.x
pubmed: 19925527
Seuthe A‑M, Ivanescu C, Leers S et al (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty—1-year results. Graefes Arch Clin Exp Ophthalmol 254:1591–1597. https://doi.org/10.1007/s00417-016-3370-6
doi: 10.1007/s00417-016-3370-6
pubmed: 27165131
Seuthe A‑M, Szurman P, Januschowski K (2020) Canaloplasty with suprachoroidal drainage in patients with pseudoexfoliation glaucoma—four years results. Curr Eye Res 46:1–7. https://doi.org/10.1080/02713683.2020.1795203
doi: 10.1080/02713683.2020.1795203
Puska P, Tarkkanen A (2001) Exfoliation syndrome as a risk factor for cataract development five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 27:1992–1998. https://doi.org/10.1016/s0886-3350(01)00972-5
doi: 10.1016/s0886-3350(01)00972-5
pubmed: 11738916
Ruotsalainen J, Tarkkanen A (1987) Capsule thickness of cataractous lenses with and without exfoliation syndrome. Acta Ophthalmol 65:444–449. https://doi.org/10.1111/j.1755-3768.1987.tb07021.x
doi: 10.1111/j.1755-3768.1987.tb07021.x
Jehan FS, Mamalis N, Crandall AS (2001) Spontaneous late dislocation of intraocular lens within the capsular bag in pseudoexfoliation patients. Ophthalmology 108:1727–1731. https://doi.org/10.1016/s0161-6420(01)00710-2
doi: 10.1016/s0161-6420(01)00710-2
pubmed: 11581041
Damji KF, Konstas AGP, Liebmann JM et al (2006) Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol 90:1014. https://doi.org/10.1136/bjo.2006.091447
doi: 10.1136/bjo.2006.091447
pubmed: 16672324
pmcid: 1857224
Kristianslund O, Østern AE, Råen M et al (2016) Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta Ophthalmol 94:261–265. https://doi.org/10.1111/aos.12945
doi: 10.1111/aos.12945
pubmed: 26749122
Jacobi PC, Dietlein TS, Krieglstein GK (1998) Bimanual trabecular aspiration in pseudoexfoliation glaucoma an alternative in nonfiltering glaucoma surgery. Ophthalmology 105:886–894. https://doi.org/10.1016/s0161-6420(98)95032-1
doi: 10.1016/s0161-6420(98)95032-1
pubmed: 9593393
Ferguson TJ, Swan RJ, Bleeker A et al (2020) Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J Cataract Refract Surg 46:1284–1289. https://doi.org/10.1097/j.jcrs.0000000000000243
doi: 10.1097/j.jcrs.0000000000000243
pubmed: 32398472
Pahlitzsch M, Gonnermann J, Maier A‑K et al (2015) Trabekulotomie ab interno (Trabectome) – Kumulierte klinische Ergebnisse eines großen Glaukomkollektivs. Klin Monbl Augenheilkd 232:1198–1207. https://doi.org/10.1055/s-0041-105941
doi: 10.1055/s-0041-105941
pubmed: 26512851
Iwasaki K, Takamura Y, Orii Y et al (2020) Performances of glaucoma operations with Kahook dual blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients. Int J Ophthalmol 13:941–945. https://doi.org/10.18240/ijo.2020.06.13
doi: 10.18240/ijo.2020.06.13
pubmed: 32566506
pmcid: 7270257
Siddiqui Y, Hulzen RDT, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799. https://doi.org/10.1016/s0002-9394(02)02289-4
doi: 10.1016/s0002-9394(02)02289-4
pubmed: 12788118
Scuderi G, Contestabile MT, Scuderi L et al (2019) Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol 39:1651–1662. https://doi.org/10.1007/s10792-018-0938-7
doi: 10.1007/s10792-018-0938-7
pubmed: 29721842
Niyadurupola N, Broadway DC (2008) Pigment dispersion syndrome and pigmentary glaucoma—a major review. Clin Exp Ophthalmol 36:868–882. https://doi.org/10.1111/j.1442-9071.2009.01920.x
doi: 10.1111/j.1442-9071.2009.01920.x
pubmed: 19278484
Karickhoff JR (1992) Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg Lasers Imaging Retina 23:269–277. https://doi.org/10.3928/1542-8877-19920401-11
doi: 10.3928/1542-8877-19920401-11
Breingan PJ, Esaki K, Ishikawa H et al (1999) Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol 117:325–328. https://doi.org/10.1001/archopht.117.3.325
doi: 10.1001/archopht.117.3.325
pubmed: 10088809
Gupta N, Weinreb RN (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41. https://doi.org/10.1097/00055735-199704000-00007
doi: 10.1097/00055735-199704000-00007
pubmed: 10168355
Lichter PR, Shaffer RN (1970) Diagnostic and prognostic signs in pigmentary glaucoma. Trans Am Acad Ophthalmol Otolaryngol 74:984–998
pubmed: 5506872
Ritch R, Liebmann J, Robin A et al (1993) Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 100:909–913. https://doi.org/10.1016/s0161-6420(93)31555-1
doi: 10.1016/s0161-6420(93)31555-1
pubmed: 8510905
Ayala M (2014) Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. J Glaucoma 23:616–619. https://doi.org/10.1097/ijg.0b013e318287abb7
doi: 10.1097/ijg.0b013e318287abb7
pubmed: 23429632
Harasymowycz PJ, Papamatheakis DG, Latina M et al (2005) Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 139:1110–1113. https://doi.org/10.1016/j.ajo.2004.11.038
doi: 10.1016/j.ajo.2004.11.038
pubmed: 15953448
Okafor K, Vinod K, Gedde SJ (2017) Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 28:154–160. https://doi.org/10.1097/icu.0000000000000352
doi: 10.1097/icu.0000000000000352
pubmed: 27898469
Setlur VJ, Parikh JG, Rao NA (2010) Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol 248:593–597. https://doi.org/10.1007/s00417-009-1262-8
doi: 10.1007/s00417-009-1262-8
pubmed: 20016910
Havens SJ, Gulati V (2015) Neovascular glaucoma. Dev Ophthalmol 55:196–204. https://doi.org/10.1159/000431196
doi: 10.1159/000431196
pubmed: 26501989
pmcid: 5664957
Lin P‑A, Lee C‑Y, Huang F‑C et al (2020) Trend of neovascular nlaucoma in Taiwan: a 15-year nationwide population-based cohort study. Ophthalmic Epidemiol 27:1–9. https://doi.org/10.1080/09286586.2020.1755445
doi: 10.1080/09286586.2020.1755445
Browning DJ, Scott AQ, Peterson CB et al (1998) The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 105:776–784. https://doi.org/10.1016/s0161-6420(98)95014-x
doi: 10.1016/s0161-6420(98)95014-x
pubmed: 9593375
Blinder KJ, Friedman SM, Mames RN (1995) Diabetic iris neovascularization. Am J Ophthalmol 120:393–395. https://doi.org/10.1016/s0002-9394(14)72173-7
doi: 10.1016/s0002-9394(14)72173-7
pubmed: 7544957
No authors listed (1993) Baseline and early natural history report: the central vein occlusion study. Arch Ophthalmol 111:1087–1095. https://doi.org/10.1001/archopht.1993.01090080083022
doi: 10.1001/archopht.1993.01090080083022
Tasman W, Magargal LE, Augsburger JJ (1980) Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87:400–402. https://doi.org/10.1016/s0161-6420(80)35225-1
doi: 10.1016/s0161-6420(80)35225-1
pubmed: 6157141
Armaly MF, Baloglou PJ (1967) Diabetes mellitus and the eye: 1. Changes in the anterior segment. Arch Ophthalmol 77:485–492. https://doi.org/10.1001/archopht.1967.00980020487011
doi: 10.1001/archopht.1967.00980020487011
pubmed: 6022720
Madsen PH (1971) Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients. Br J Ophthalmol 55:444–450. https://doi.org/10.1136/bjo.55.7.444
doi: 10.1136/bjo.55.7.444
pubmed: 5557520
pmcid: 1208416
Ohrt V (1971) The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol 49:301–307. https://doi.org/10.1111/j.1755-3768.1971.tb00954.x
doi: 10.1111/j.1755-3768.1971.tb00954.x
Nielsen NV (1983) The prevanlence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol 61:662–672. https://doi.org/10.1111/j.1755-3768.1983.tb04357.x
doi: 10.1111/j.1755-3768.1983.tb04357.x
Rudkin AK, Lee AW, Chen CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20:1042–1046. https://doi.org/10.1177/112067211002000603
doi: 10.1177/112067211002000603
pubmed: 20544682
Neupert JR, Brubaker RF, Kearns TP et al (1976) Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 81:600–602. https://doi.org/10.1016/0002-9394(76)90123-9
doi: 10.1016/0002-9394(76)90123-9
pubmed: 1275038
Ohnishi Y, Ishibashi T, Sagawa T (1994) Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 232:199–204. https://doi.org/10.1007/bf00184005
doi: 10.1007/bf00184005
pubmed: 7518405
Horsley MB, Kahook MY (2010) Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 21:112–117. https://doi.org/10.1097/icu.0b013e3283360aad
doi: 10.1097/icu.0b013e3283360aad
pubmed: 20040875
Wakabayashi T, Oshima Y, Sakaguchi H et al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571–1580.e3. https://doi.org/10.1016/j.ophtha.2008.02.026
doi: 10.1016/j.ophtha.2008.02.026
pubmed: 18440643
Yazdani S, Hendi K, Pakravan M et al (2009) Intravitreal bevacizumab for neovascular glaucoma. J Glaucoma 18:632–637. https://doi.org/10.1097/ijg.0b013e3181997211
doi: 10.1097/ijg.0b013e3181997211
pubmed: 19826393
Olmos LC, Sayed MS, Moraczewski AL et al (2016) Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond) 30:463–472. https://doi.org/10.1038/eye.2015.259
doi: 10.1038/eye.2015.259
Takihara Y, Inatani M, Fukushima M et al (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912–918.e1. https://doi.org/10.1016/j.ajo.2008.11.015
doi: 10.1016/j.ajo.2008.11.015
pubmed: 19195639
Shen CC, Salim S, Du H, Netland PA (2011) Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol 5:281–286. https://doi.org/10.2147/opth.s16976
doi: 10.2147/opth.s16976
pubmed: 21468334
pmcid: 3065568
Ghosh S, Singh D, Ruddle JB et al (2010) Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exp Ophthalmol 38:353–357. https://doi.org/10.1111/j.1442-9071.2010.02285.x
doi: 10.1111/j.1442-9071.2010.02285.x
pubmed: 20665941
Iliev ME, Gerber S (2007) Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 91:1631–1635. https://doi.org/10.1136/bjo.2007.116533
doi: 10.1136/bjo.2007.116533
pubmed: 17494956
pmcid: 2095557
Murphy CC, Burnett CAM, Spry PGD et al (2003) A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 87:1252. https://doi.org/10.1136/bjo.87.10.1252
doi: 10.1136/bjo.87.10.1252
pubmed: 14507761
pmcid: 1920778
Yildirim N, Yalvac IS, Sahin A et al (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. J Glaucoma 18:192–196. https://doi.org/10.1097/ijg.0b013e31817d235c
doi: 10.1097/ijg.0b013e31817d235c
pubmed: 19295370
Strzalkowski P, Strzalkowska A, Göbel W et al (2020) Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma — a retrospective interventional case series. F1000Res 9:1236. https://doi.org/10.12688/f1000research.26879.2
doi: 10.12688/f1000research.26879.2
pubmed: 33796275